Cargando...
HER2-Orientated Therapy in Early and Metastatic Breast Cancer
Due to the enhanced understanding of molecular oncology and signaling pathways in breast cancer (BC), therapy management has undergone a major transformation, especially with the emergence of treatment tailored to individual disease characteristics. In the case of HER2-positive early or metastatic B...
Guardado en:
| Publicado en: | Breast Care (Basel) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger GmbH
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290438/ https://ncbi.nlm.nih.gov/pubmed/28228705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000453603 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|